Article Details
Retrieved on: 2025-02-14 22:22:38
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses a study linking GLP-1 receptor agonists, such as semaglutide, used for type 2 diabetes and obesity, to vision problems. It highlights non-arteritic anterior ischemic optic neuropathy, underscoring the need for more epidemiologic research correlating these drugs with eye issues. Tags emphasize potential drug impacts on diabetes-related health outcomes.
Article found on: www.foxnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here